BlackRock’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-431,406
Closed -$1.15M 5350
2024
Q1
$1.15M Sell
431,406
-155,282
-26% -$413K ﹤0.01% 4107
2023
Q4
$1.39M Sell
586,688
-154,662
-21% -$367K ﹤0.01% 4083
2023
Q3
$1.04M Buy
741,350
+18,348
+3% +$25.7K ﹤0.01% 4168
2023
Q2
$2.19M Sell
723,002
-1,554,107
-68% -$4.71M ﹤0.01% 3935
2023
Q1
$14.2M Sell
2,277,109
-58,709
-3% -$367K ﹤0.01% 3075
2022
Q4
$14.2M Buy
2,335,818
+59,002
+3% +$360K ﹤0.01% 3147
2022
Q3
$27.2M Sell
2,276,816
-22,728
-1% -$272K ﹤0.01% 2825
2022
Q2
$29M Buy
2,299,544
+244,320
+12% +$3.08M ﹤0.01% 2824
2022
Q1
$23.1M Buy
2,055,224
+8,189
+0.4% +$92.2K ﹤0.01% 3016
2021
Q4
$36.3M Buy
2,047,035
+172,674
+9% +$3.06M ﹤0.01% 2848
2021
Q3
$43.1M Buy
1,874,361
+600,832
+47% +$13.8M ﹤0.01% 2732
2021
Q2
$29.6M Buy
1,273,529
+63,331
+5% +$1.47M ﹤0.01% 3015
2021
Q1
$37.7M Buy
1,210,198
+900,654
+291% +$28.1M ﹤0.01% 2766
2020
Q4
$12.3M Buy
+309,544
New +$12.3M ﹤0.01% 3199